{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:04:51Z","timestamp":1763035491114,"version":"build-2065373602"},"reference-count":146,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1067\/mjd.2000.109069","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:17:08Z","timestamp":1027556228000},"page":"S81-S95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"S","title":["Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States"],"prefix":"10.1067","volume":"43","author":[{"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2000.109069_bib1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0190-9622(08)81495-8","article-title":"Antifungal agents: an overview. Part I","volume":"30","author":"Gupta","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0190-9622(94)70112-1","article-title":"Antifungal agents: an overview. Part II","volume":"30","author":"Gupta","year":"1994","journal-title":"J Am Acad Dermatol"},{"year":"1999","series-title":"Ciclopirox lacquer topical solution 8% [package insert]","key":"10.1067\/mjd.2000.109069_bib3"},{"issue":"suppl 43","key":"10.1067\/mjd.2000.109069_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2133.1994.tb06093.x","article-title":"A multi-national pharmacoeconomic analysis of oral therapies for onychomycosis","volume":"130","author":"Arikian","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000246254","article-title":"Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany","volume":"193","author":"Van Doorslaer","year":"1996","journal-title":"Dermatology"},{"key":"10.1067\/mjd.2000.109069_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00019053-199813020-00007","article-title":"Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails: a US analysis","volume":"13","author":"Gupta","year":"1998","journal-title":"PharmacoEconomics"},{"key":"10.1067\/mjd.2000.109069_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.1999.tb00837.x","article-title":"The new oral agents for onychomycosis of the toenails","volume":"13","author":"Gupta","year":"1999","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1067\/mjd.2000.109069_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200022010-00004","article-title":"An update, with a risk-benefit evaluation of the newer oral antifungal agents to treat onychomycosis","volume":"22","author":"Gupta","year":"2000","journal-title":"Drug Safety"},{"key":"10.1067\/mjd.2000.109069_bib9","first-page":"19","article-title":"Pharmacokinetic properties","author":"Clissold","year":"1987"},{"key":"10.1067\/mjd.2000.109069_bib10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0190-9622(91)70214-M","article-title":"Ketoconazole-induced fulminant hepatitis necessitating liver transplantation","volume":"25","author":"Knight","year":"1991","journal-title":"J Am Acad Dermatol"},{"first-page":"1345","year":"1997","author":"Ketoconazole","key":"10.1067\/mjd.2000.109069_bib11"},{"key":"10.1067\/mjd.2000.109069_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0733-8635(05)70420-4","article-title":"Current management of onychomycosis: an overview","volume":"15","author":"Gupta","year":"1997","journal-title":"Dermatol Clin"},{"key":"10.1067\/mjd.2000.109069_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archderm.1996.03890250044008","article-title":"Itraconazole pulse therapy is effective in the treatment of onychomycosis: a pharmacokinetic\/ pharmacodynamic and clinical evaluation","volume":"132","author":"De Doncker","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1046\/j.1365-4632.1998.00564.x","article-title":"Fluconazole for the treatment of onychomycosis: an update","volume":"37","author":"Gupta","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-4362.1991.tb02648.x","article-title":"Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent","volume":"30","author":"Arenas","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/09546639709160278","article-title":"Comparative multicenter double-blind study of terbinafine (250 mg per day) versus griseofulvin (1 g per day) in the treatment of dermatophyte onychomycosis","volume":"8","author":"Baran","year":"1997","journal-title":"J Dermatol Treat"},{"key":"10.1067\/mjd.2000.109069_bib17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/0190-9622(95)91454-4","article-title":"Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis","volume":"32","author":"Faergemann","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archderm.1995.01690200057011","article-title":"Treatment of toenail onychomycosis: a randomized, double-blind study with terbinafine and griseofulvin","volume":"131","author":"Hofmann","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2340\/0001555570137140","article-title":"Itraconazole in onychomycosis: open and double-blind studies","volume":"70","author":"Wals\u00f8e","year":"1990","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1067\/mjd.2000.109069_bib20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-4362.1995.tb03600.x","article-title":"Open randomized comparison of itraconazole versus terbinafine in onychomycosis","volume":"34","author":"Arenas","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/bmj.311.7010.919","article-title":"Randomized double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection","volume":"311","author":"Br\u00e4utigam","year":"1995","journal-title":"Br Med J"},{"issue":"suppl 46","key":"10.1067\/mjd.2000.109069_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2133.1996.tb15653.x","article-title":"A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg\/day vs itraconazole 200 mg\/day\u2014a double-blind comparative trial","volume":"134","author":"De Backer","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/000155599750011020","article-title":"Randomized double-blind comparison of short term itraconazole and terbinafine therapy for toenail onychomycosis","volume":"79","author":"Degreef","year":"1999","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1067\/mjd.2000.109069_bib24","first-page":"217","article-title":"Double-blind, randomized comparison of itraconazole capsules vs placebo in the treatment of toenail onychomycosis","volume":"59","author":"Elewski","year":"1997","journal-title":"Cutis"},{"key":"10.1067\/mjd.2000.109069_bib25","first-page":"7","article-title":"The use of itraconazole in onychomycosis","volume":"6","author":"Haneke","year":"1996","journal-title":"Eur J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000017905","article-title":"Itraconazole in the treatment of onychomycosis: a double-blind comparison with miconazole","volume":"196","author":"Haneke","year":"1998","journal-title":"Dermatology"},{"key":"10.1067\/mjd.2000.109069_bib27","first-page":"230","article-title":"A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toenail onychomycosis","volume":"136","author":"Havu","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1468-3083.1997.tb00505.x","article-title":"Itraconazole versus terbinafine (Lamisil): which is better for the treatment of onychomycosis?","volume":"9","author":"Honeyman","year":"1997","journal-title":"J Eur Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-4362.1996.tb03667.x","article-title":"Double-blind, randomized comparison of itraconazole capsules and placebo in the treatment of onychomycosis of the toenail","volume":"35","author":"Jones","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0190-9622(96)90519-8","article-title":"A double blind randomized comparison of itraconazole capsules and placebo in the treatment of onychomycosis of the toenail","volume":"35","author":"Odom","year":"1996","journal-title":"J Am Acad Dermatol"},{"year":"1996","series-title":"Itraconazole [package insert]","key":"10.1067\/mjd.2000.109069_bib31"},{"key":"10.1067\/mjd.2000.109069_bib32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-4362.1997.00025.x","article-title":"Itraconazole in onychomycosis: intermittent dose schedule","volume":"36","author":"Bonifaz","year":"1997","journal-title":"Int J Dermatol"},{"year":"1997","series-title":"Itraconazole [package insert]","key":"10.1067\/mjd.2000.109069_bib33"},{"key":"10.1067\/mjd.2000.109069_bib34","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/bmj.318.7190.1031","article-title":"Double-blind randomized study of continuous terbinafine compared with intermittent itraconazole in the treatment of toenail onychomycosis","volume":"318","author":"Evans","year":"1999","journal-title":"Br Med J"},{"key":"10.1067\/mjd.2000.109069_bib35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1439-0507.1998.tb00330.x","article-title":"An intermittent 1-week dosing regimen for the treatment of toenail onychomycosis in dermatological patients","volume":"41","author":"Ginter","year":"1998","journal-title":"Mycoses"},{"key":"10.1067\/mjd.2000.109069_bib36","first-page":"737","article-title":"The safety and efficacy of intermittent therapy with itraconazole for finger and toenail onychomycosis: a multicenter trial","volume":"10","author":"Haneke","year":"1997","journal-title":"Zeitschriftfuer Hautkrankheiten"},{"issue":"suppl","key":"10.1067\/mjd.2000.109069_bib37","first-page":"12","article-title":"Itraconazole pulse therapy vs terbinafine continuous dosing for toenail onychomycosis","author":"Kejda","year":"1999","journal-title":"Postgrad Med"},{"key":"10.1067\/mjd.2000.109069_bib38","first-page":"8","article-title":"Treatment of onychomycosis due to mycelial fungi","volume":"21","author":"Negroni","year":"1998","journal-title":"Revista Argentina de Micologica"},{"year":"1998","author":"Svejgaard","key":"10.1067\/mjd.2000.109069_bib39"},{"key":"10.1067\/mjd.2000.109069_bib40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0190-9622(96)80057-0","article-title":"Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy","volume":"34","author":"Tosti","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000018177","article-title":"Therapeutic efficacy and safety of 1-week intermittent therapy with itraconazole for onychomycosis in a Chinese patient population","volume":"199","author":"Wang","year":"1999","journal-title":"Dermatology"},{"key":"10.1067\/mjd.2000.109069_bib42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1346-8138.1996.tb04009.x","article-title":"Intermittent therapy with terbinafine for dermatophyte toe onychomycosis: a new approach","volume":"23","author":"Alpsoy","year":"1996","journal-title":"J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib43","first-page":"39","article-title":"Terbinafine (Lamisil) 250 mg\/day and 500 mg\/day are equally effective in a 16 week oral treatment of toenail onychomycosis: a double-blind multicentre trial","author":"De Backer","year":"1994"},{"key":"10.1067\/mjd.2000.109069_bib44","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/bmj.304.6835.1151","article-title":"Short-term treatment of dermatophyte onychomycosis with terbinafine","volume":"304","author":"Goodfield","year":"1992","journal-title":"Br Med J"},{"issue":"suppl 2","key":"10.1067\/mjd.2000.109069_bib45","first-page":"S154","article-title":"A study to compare the efficacy of Lamisil (terbinafine) and Diflucan (fluconazole) in patients with onychomycosis [abstract]","volume":"7","author":"Havu","year":"1996","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1067\/mjd.2000.109069_bib46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2340\/0001555555776669","article-title":"Oral terbinafine in toenail dermatophytosis","volume":"77","author":"Svejgaard","year":"1997","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1067\/mjd.2000.109069_bib47","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2133.1997.6661651.x","article-title":"Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy","volume":"136","author":"Tausch","year":"1997","journal-title":"Br J Dermatol"},{"year":"1996","series-title":"Terbinafine [package insert]","key":"10.1067\/mjd.2000.109069_bib48"},{"key":"10.1067\/mjd.2000.109069_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2133.1992.tb00008.x","article-title":"A randomized treatment duration-finding study of terbinafine in onychomycosis","volume":"126","author":"Van Der Schroeff","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib50","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0190-9622(95)91815-9","article-title":"Terbinafine in onychomycosis of the toenail: a novel treatment protocol","volume":"33","author":"Watson","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0011-393X(97)80040-9","article-title":"An open-label, non-comparative, multicenter evaluation of fluconazole with or without urea nail pedicure for treatment of onychomycosis","volume":"58","author":"Fr\u00e4ki","year":"1997","journal-title":"Curr Ther Res"},{"key":"10.1067\/mjd.2000.109069_bib52","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-4362.1996.tb03666.x","article-title":"Fluconazole in the treatment of severe onychomycosis","volume":"35","author":"Montero-Gei","year":"1996","journal-title":"Int J Dermatol"},{"issue":"part 2","key":"10.1067\/mjd.2000.109069_bib53","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0190-9622(98)70490-6","article-title":"Once-weekly fluconazole (150 mg, 300 mg, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail","volume":"38","author":"Scher","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib54","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2000.109071","article-title":"Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis","volume":"43","author":"Gupta","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib55","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/archderm.1960.03730050215038","article-title":"Experiences in one hundred thirty-seven patients with oral griseofulvin","volume":"81","author":"Goldfarb","year":"1960","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib56","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/archderm.1960.03730050194035","article-title":"Comparative effects of griseofulvin on onychomycosis and on psoriasis","volume":"60","author":"Kaminsky","year":"1960","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib57","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archderm.1960.03730050125022","article-title":"Griseofulvin and Trichophyton rubrum infections","volume":"81","author":"Williams","year":"1960","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib58","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/bmj.3.5563.464","article-title":"Mycological and clinical evaluation of griseofulvin for chronic onychomycosis","volume":"3","author":"Davies","year":"1967","journal-title":"Br Med J"},{"key":"10.1067\/mjd.2000.109069_bib59","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1128\/AAC.37.10.2064","article-title":"Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole","volume":"37","author":"Korting","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1067\/mjd.2000.109069_bib60","first-page":"1140","article-title":"Chronic ringworm infection of the skin and nails treated with griseofulvin","volume":"1","author":"Russell","year":"1960","journal-title":"Lancet"},{"key":"10.1067\/mjd.2000.109069_bib61","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2133.1985.tb02338.x","article-title":"A comparative double-blind study of ketoconazole and griseofulvin in dermatophytosis","volume":"112","author":"Hay","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jac\/29.2.195","article-title":"Efficacy and safety of itraconazole in the long-term treatment of onychomycosis","volume":"29","author":"Piepponen","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1067\/mjd.2000.109069_bib63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0140-6736(61)91538-0","article-title":"Chronic ringworm of the nails","volume":"1","author":"Stevenson","year":"1961","journal-title":"Lancet"},{"key":"10.1067\/mjd.2000.109069_bib64","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/archderm.1960.03730050183033","article-title":"Use of griseofulvin in office practice","volume":"81","author":"Levin","year":"1960","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib65","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7547\/87507315-56-3-119","article-title":"Onychomycosis treated with ultrafine griseofulvin","volume":"56","author":"Quintaville","year":"1966","journal-title":"J Am Podiatr Assoc"},{"key":"10.1067\/mjd.2000.109069_bib66","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1001\/archderm.1960.03730050146026","article-title":"Dosage requirements of griseofulvin in onychomycosis due to Trichophyton rubrum","volume":"81","author":"Dillaha","year":"1960","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib67","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1001\/jama.1959.03010340012003","article-title":"Griseofulvin for the systemic treatment of dermatomycoses","volume":"171","author":"Blank","year":"1959","journal-title":"JAMA"},{"key":"10.1067\/mjd.2000.109069_bib68","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archderm.1960.03730050089015","article-title":"Short-term treatment of onychomycosis with griseofulvin","volume":"18","author":"Maibach","year":"1960","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib69","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/archderm.1960.03730050189034","article-title":"New schemes in the treatment of dermatophytoses with griseofulvin","volume":"81","author":"Gonz'lez-Ochoa","year":"1960","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib70","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0190-9622(95)90187-6","article-title":"Short-duration treatment of fingernail dermatophytosis: a randomized, double-blind study with terbinafine and griseofulvin","volume":"32","author":"Haneke","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib71","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2133.1960.tb13820.x","article-title":"The treatment of onychomycosis with griseofulvin","volume":"72","author":"Hargreaves","year":"1960","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib72","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0190-9622(95)91361-0","article-title":"Onychomycosis caused by Microsporum canis: treatment with itraconazole","volume":"32","author":"Andr\u00e9","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib73","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0190-9622(88)70109-7","article-title":"Itraconazole therapy for recalcitrant dermatophyte infections","volume":"18","author":"Hanifin","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib74","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/09546639209092742","article-title":"Treatment of onychomycosis with itraconazole","volume":"2","author":"Rongioletti","year":"1992","journal-title":"J Dermatol Treat"},{"key":"10.1067\/mjd.2000.109069_bib75","unstructured":"Stary A, Storch M, H\u00f6rting-M\u00fcller I. Systemic treatment of onychomycosis with itraconazole: clinical and mycological results [abstract]. 3rd Congress of the European Academy of Dermatology and Venereology 1993 Sept 26-30; Copenhagen, 348."},{"key":"10.1067\/mjd.2000.109069_bib76","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2133.1988.tb03229.x","article-title":"An evaluation of itraconazole in the management of onychomycosis","volume":"119","author":"Hay","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archderm.1994.01690010023002","article-title":"Candidiasis endocrinopathy syndrome","volume":"130","author":"DePadova-Elder","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib78","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/0011-393X(95)85113-5","article-title":"Efficacy and tolerability of itraconazole in patients with fingernail onychomycosis: a 6-week pilot study","volume":"56","author":"Kim","year":"1995","journal-title":"Curr Ther Res"},{"key":"10.1067\/mjd.2000.109069_bib79","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0190-9622(97)70275-5","article-title":"Itraconazole therapy is effective for pedal onychomycosis caused by some non-dermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 35 patients","volume":"36","author":"De Doncker","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib80","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2133.1988.tb01749.x","article-title":"Candida onychomycosis: an evaluation of the role of Candida species in nail disease","volume":"118","author":"Hay","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib81","first-page":"371","article-title":"Itraconazole therapy for onychomycosis: case reports","volume":"58","author":"Krishbaum","year":"1996","journal-title":"Cutis"},{"key":"10.1067\/mjd.2000.109069_bib82","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1525-1470.1997.tb00223.x","article-title":"Itraconazole in the treatment of two young brothers with chronic mucocutaneous candidiasis","volume":"14","author":"Tosti","year":"1997","journal-title":"Pediatr Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib83","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0190-9622(92)70102-L","article-title":"Posttreatment itraconazole levels in the nail","volume":"26","author":"Willemsen","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib84","first-page":"180","article-title":"Pulse therapy with one-week itraconazole monthly for three or four months in the treatment of onychomycosis","volume":"56","author":"De Doncker","year":"1995","journal-title":"Cutis"},{"key":"10.1067\/mjd.2000.109069_bib85","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1439-0507.1997.tb00258.x","article-title":"Small-dose itraconazole pulse therapy in the treatment of onychomycosis","volume":"40","author":"Wu","year":"1997","journal-title":"Mycoses"},{"key":"10.1067\/mjd.2000.109069_bib86","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1468-3083.1998.tb00762.x","article-title":"Efficacy and safety of itraconazole pulse therapy: Brazilian multicentric study on toenail onychomycosis caused by dermatophytes","volume":"11","author":"Ramos-e-Silva","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1067\/mjd.2000.109069_bib87","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000246433","article-title":"Yellow nail syndrome and onychomycosis","volume":"192","author":"Luyton","year":"1996","journal-title":"Dermatology"},{"key":"10.1067\/mjd.2000.109069_bib88","first-page":"253","article-title":"Trichophyton rubrum onychomycosis in a 17-year-old girl","volume":"60","author":"Elewski","year":"1997","journal-title":"Cutis"},{"key":"10.1067\/mjd.2000.109069_bib89","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0190-9622(97)70286-X","article-title":"A multicenter, placebo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the fingernail","volume":"36","author":"Odom","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib90","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1439-0507.1999.00404.x","article-title":"A comparison among four regimens of itraconazole treatment in onychomycosis","volume":"42","author":"Chen","year":"1999","journal-title":"Mycoses"},{"key":"10.1067\/mjd.2000.109069_bib91","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-4362.1996.tb03645.x","article-title":"Onychomycosis treated with a short course of oral terbinafine","volume":"35","author":"Galimberti","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib92","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1439-0507.1995.tb00051.x","article-title":"Short therapy for tinea unguium with terbinafine: four different courses of treatment","volume":"38","author":"Albanese","year":"1995","journal-title":"Mycoses"},{"key":"10.1067\/mjd.2000.109069_bib93","first-page":"174","article-title":"Terbinafine and onychomycosis [abstract]","volume":"181","author":"Rakosi","year":"1990","journal-title":"Dermatologica"},{"key":"10.1067\/mjd.2000.109069_bib94","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/0140-6736(92)90595-T","article-title":"Single dose treatment of fungal nail disease [letter]","volume":"339","author":"Shuster","year":"1992","journal-title":"Lancet"},{"key":"10.1067\/mjd.2000.109069_bib95","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0190-9622(90)70295-S","article-title":"Management of onychomycosis with oral terbinafine","volume":"23","author":"Zaias","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib96","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2133.1992.tb00009.x","article-title":"Treatment of onychomycosis with terbinafine","volume":"126","author":"Baudraz-Rosselet","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib97","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-2133.1989.tb08217.x","article-title":"Treatment of dermatophyte infection of the finger- and toenails with terbinafine (SF 86-327, Lamisil), an orally active fungicidal agent","volume":"121","author":"Goodfield","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib98","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2133.1992.tb00007.x","article-title":"Short-duration therapy with terbinafine for dermatophyte onychomycosis: a multicentre trial","volume":"126","author":"Goodfield","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib99","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/09546639009089036","article-title":"Clinical results with terbinafine in onychomycosis","volume":"1","author":"Goodfield","year":"1990","journal-title":"J Dermatol Treat"},{"key":"10.1067\/mjd.2000.109069_bib100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2230.1989.tb00907.x","article-title":"The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine","volume":"14","author":"Zaias","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib101","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-4362.1993.tb01420.x","article-title":"Terbinafine in onychomycosis: a mini study","volume":"32","author":"Savin","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib102","first-page":"17","article-title":"Terbinafine and onychomycosis [letter]","volume":"104","author":"Eastcott","year":"1991","journal-title":"N Z Med J"},{"key":"10.1067\/mjd.2000.109069_bib103","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2133.1995.tb02644.x","article-title":"Very short duration therapy with oral terbinafine for fingernail onychomycosis","volume":"133","author":"Wong","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib104","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2133.1994.tb06088.x","article-title":"Terbinafine in onychomycosis with involvement by non-dermatophytic fungi","volume":"130","author":"Nolting","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib105","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0190-9622(96)90120-6","article-title":"Treatment of Candida nail infections with terbinafine","volume":"35","author":"Segal","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib106","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/09546639209088701","article-title":"Terbinafine in chronic paronychia and Candida onychomycosis","volume":"3","author":"Roberts","year":"1992","journal-title":"J Dermatol Treat"},{"key":"10.1067\/mjd.2000.109069_bib107","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2133.1996.tb03895.x","article-title":"Onychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals","volume":"135","author":"Tosti","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib108","first-page":"1488","article-title":"Study of the efficacy and tolerability of oral terbinafine in the treatment of onychomycosis in renal transplant patients","volume":"28","author":"Lee","year":"1996","journal-title":"Transplant Proc"},{"key":"10.1067\/mjd.2000.109069_bib109","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-2133.1995.tb02513.x","article-title":"Treatment of onychomycosis with terbinafine in patients with Down's syndrome","volume":"133","author":"Velthuis","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1439-0507.1998.tb00379.x","article-title":"Long-term post-treatment follow-up of onychomycosis treated with terbinafine: a multicentre trial","volume":"41","author":"T\u00f6r\u00f6k","year":"1998","journal-title":"Mycoses"},{"key":"10.1067\/mjd.2000.109069_bib111","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2133.1995.tb02644.x","article-title":"Very short duration therapy with oral terbinafine for fingernail onychomycosis","volume":"133","author":"Wong","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib112","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2133.1996.tb15655.x","article-title":"Use of terbinafine in HIV-positive subjects: pilot studies in onychomycosis and oral candidiasis","volume":"134","author":"Nandwani","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib113","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2133.1997.tb03789.x","article-title":"Toenail onychomycosis in patients with acquired immune deficiency syndrome: treatment with terbinafine","volume":"137","author":"Herranz","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib114","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1365-4362.1999.00713.x","article-title":"Terbinafine vs placebo for onychomycosis in black patients","volume":"38","author":"Billstein","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/09546639209088703","article-title":"Fluconazole in the treatment of onychomycosis caused by dermatophytes","volume":"3","author":"Kuokkanen","year":"1992","journal-title":"J Dermatol Treat"},{"key":"10.1067\/mjd.2000.109069_bib116","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0190-9622(98)70491-8","article-title":"Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail","volume":"38","author":"Drake","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib117","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/S0190-9622(98)70492-X","article-title":"Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail","volume":"38","author":"Ling","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib118","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/S0190-9622(98)70493-1","article-title":"Pharmacokinetics of three doses of once-weekly fluconazole (1250, 300, and 450 mg) in distal subungual onychomycosis of the toenail","volume":"38","author":"Rich","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib119","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/S0190-9622(98)70494-3","article-title":"Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail","volume":"38","author":"Savin","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib120","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0190-9622(96)90327-8","article-title":"Intermittent fluconazole dosing in patients with onychomycosis: results of a pilot study","volume":"35","author":"Assaf","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib121","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1525-1470.1996.tb00732.x","article-title":"Successful treatment of onychomycosis with fluconazole in two patients with hyperimmunoglobulin E syndrome","volume":"13","author":"Aihara","year":"1996","journal-title":"Pediatr Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib122","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/00007611-199512000-00006","article-title":"An evaluation of the safety and efficacy of fluconazole in the treatment of onychomycosis","volume":"88","author":"Smith","year":"1995","journal-title":"South Med J"},{"key":"10.1067\/mjd.2000.109069_bib123","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archderm.1992.01680170037002","article-title":"Recalcitrant onychomycosis of the toenails successfully treated with fluconazole","volume":"28","author":"Coldiron","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib124","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000247304","article-title":"Onychomycosis: successful treatment with once-weekly fluconazole","volume":"186","author":"Nahass","year":"1993","journal-title":"Dermatology"},{"key":"10.1067\/mjd.2000.109069_bib125","first-page":"169","article-title":"The safety and efficacy of oral fluconazole in the treatment of onychomycosis","volume":"1","author":"Hochman","year":"1993","journal-title":"J Geriatr Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib126","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1067\/mjd.2000.109069_bib127","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0306-9877(91)90232-N","article-title":"Meta-analysis for combining Bayesian probabilities","volume":"35","author":"Velanovich","year":"1991","journal-title":"Med Hypotheses"},{"issue":"suppl 39","key":"10.1067\/mjd.2000.109069_bib128","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2133.1992.tb00013.x","article-title":"Special features of the clinical use of oral terbinafine in the treatment of fungal diseases","volume":"126","author":"Villars","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib129","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0190-9622(97)70074-4","article-title":"Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview","volume":"37","author":"De Doncker","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"part 2","key":"10.1067\/mjd.2000.109069_bib130","first-page":"S77","article-title":"Once-weekly fluconazole in the treatment of onychomycosis","volume":"38","author":"Elewski","year":"1998","journal-title":"J Am Acad Dermatol"},{"year":"1999","key":"10.1067\/mjd.2000.109069_bib131","first-page":"1"},{"year":"1995","series-title":"1995 annual Medicare physician fee schedule-carrier file","author":"Health Care Finance Administration","key":"10.1067\/mjd.2000.109069_bib132"},{"year":"1995","series-title":"1995 clinical diagnostic lab fee schedule-carrier file","author":"Health Care Finance Administration","key":"10.1067\/mjd.2000.109069_bib133"},{"issue":"suppl 2","key":"10.1067\/mjd.2000.109069_bib134","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-4362.1999.00012.x","article-title":"Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA","volume":"38","author":"Gupta","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib135","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1067\/mjd.2000.109072","article-title":"Dermatopharmacology of ciclopirox nail lacquer, topical solution 8% in the treatment of onychomycosis","volume":"43","author":"Bohn","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib136","first-page":"1","article-title":"Hydroxy-pyridones outstanding biological properties","author":"Markus","year":"1999"},{"key":"10.1067\/mjd.2000.109069_bib137","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1067\/mjd.2000.109068","article-title":"The role of ciclopirox nail lacquer solution 8% in the 21st century","volume":"43","author":"Gupta","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib138","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0733-8635(05)70460-5","article-title":"Oral antifungal drug interactions","volume":"15","author":"Katz","year":"1997","journal-title":"Dermatol Clin"},{"key":"10.1067\/mjd.2000.109069_bib139","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0190-9622(99)70055-1","article-title":"Drug interactions with itraconazole, fluconazole, and terbinafine, and their management","volume":"41","author":"Gupta","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.109069_bib140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/003693309704200506","article-title":"Adverse drug reactions in the elderly and their prevention","volume":"42","author":"Cunningham","year":"1997","journal-title":"Scott Med J"},{"key":"10.1067\/mjd.2000.109069_bib141","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00002512-199812060-00006","article-title":"Important drug-drug interactions in the elderly","volume":"12","author":"Seymour","year":"1998","journal-title":"Drugs Aging"},{"issue":"suppl 1","key":"10.1067\/mjd.2000.109069_bib142","first-page":"S29","article-title":"HIV protease inhibitors: pharmacologic and metabolic distinctions","volume":"13","author":"Sommadossi","year":"1999","journal-title":"AIDS"},{"key":"10.1067\/mjd.2000.109069_bib143","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0149-2918(96)80225-6","article-title":"Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model","volume":"18","author":"Marchetti","year":"1996","journal-title":"Clin Ther"},{"key":"10.1067\/mjd.2000.109069_bib144","first-page":"59","article-title":"Modeling the cost-effectiveness of oral therapy for nail fungus","volume":"2","author":"Halpern","year":"1996","journal-title":"Am J Managed Care"},{"key":"10.1067\/mjd.2000.109069_bib145","first-page":"443","article-title":"A cost\/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine","volume":"3","author":"Angello","year":"1997","journal-title":"Am J Managed Care"},{"key":"10.1067\/mjd.2000.109069_bib146","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0190-9622(98)70488-8","article-title":"Cost-effectiveness of two new treatments for onychomycosis: an analysis of two comparative clinical trials","volume":"38","author":"Bootman","year":"1998","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200809706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200809706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:25:05Z","timestamp":1759267505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962200809706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":146,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["S0190962200809706"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2000.109069","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2000,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mjd.2000.109069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}